Literature DB >> 27744174

Cytokine profiles in patients with toxoplasmic lymphadenitis in the setting of pregnancy.

Christelle Pomares1, Tyson H Holmes2, Remy Estran3, Cynthia J Press4, Raymund Ramirez4, Jeanne Talucod4, Holden Maecker5, Yael Rosenberg-Hasson5, Jose G Montoya6.   

Abstract

INTRODUCTION: Majority of Toxoplasma gondii infections are benign and asymptomatic; however, some patients experience toxoplasmic lymphadenitis (TL). Factors associated as to whether infection will be symptomatic or not are unknown.
METHODS: Dye test titers of patients with acute toxoplasmosis (pregnant and not pregnant) with TL (TL+) were compared with those in patients with asymptomatic acute infection (TL-). Additionally, mean levels of 62 serum cytokines were compared between TL+ and TL- pregnant women and between TL+ pregnant and non-pregnant women.
RESULTS: During acute infection, mean dye test titer was higher in TL+ than in TL- patients (p=0.021). In addition, out of 62 cytokines, CXCL9andCXCL10 levels were higher (p<0.05) and resistin mean levels were lower (p<0.05) in pregnant women with TL+ compared to TL-. Among patients with TL+, levels of VCAM1andCCL2 were lower (p<0.05) in pregnant women than in non-pregnant women.
CONCLUSION: Here we report differences in dye test titers in patients with acute infection. Cytokine responses vary according to the presence of TL+ and to the pregnancy status. Factors underlying these differences are presently unknown and require further studies to define individual and combined roles of cytokines in TL+.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute infection; Cytokine; Pregnancy; Serology; Toxoplasmic lymphadenitis

Mesh:

Substances:

Year:  2016        PMID: 27744174     DOI: 10.1016/j.cyto.2016.09.021

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

1.  Acute Chelation Therapy-Associated Changes in Urine Gadolinium, Self-reported Flare Severity, and Serum Cytokines in Gadolinium Deposition Disease.

Authors:  Holden T Maecker; Janet C Siebert; Yael Rosenberg-Hasson; Lorrin M Koran; Miguel Ramalho; Richard C Semelka
Journal:  Invest Radiol       Date:  2021-06-01       Impact factor: 10.065

Review 2.  Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response.

Authors:  Madiha Sana; Muhammad Rashid; Imran Rashid; Haroon Akbar; Jorge E Gomez-Marin; Isabelle Dimier-Poisson
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.